Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
FDA Filing
.
Show all posts
Showing posts with label
FDA Filing
.
Show all posts
Tuesday, February 4, 2020
Epizyme Announces FDA Filing Acceptance of New Drug Application and Priority Review for Tazemetostat for the Treatment of Epithelioid Sarcoma
›
Epizyme, Inc. (Nasdaq: EPZM), a late-stage biopharmaceutical company developing novel epigenetic therapies, today announced that the U...
›
Home
View web version
